Search

Chen 2017 Background Material, FDA-2026-P-3869, Apr 3

Chen 2017 Background Material, FDA-2026-P-3869, Apr 3

Call for Nominations for Center for Indigenous Innovation and Health Tribal Advisory Committee

The HHS Office on Minority Health (OMH) is accepting nominations for primary and alternate delegates to serve on the Center for Indigenous Innovation and Health Tribal Advisory Committee (CIIH TAC). The CIIH TAC provides tribal leaders a forum to exchange views and provide feedback on activities addressing four priority areas: research, education, service, and policy development. Nomination letters must be submitted by May 18, 2026.

Advisory Council on Alzheimer's Research, Care, and Services Meeting

HHS announces a public meeting of the Advisory Council on Alzheimer's Research, Care, and Services scheduled for Monday, April 27, 2026, from 1:00 p.m. to 5:00 p.m. The meeting is open to the public for attendance and comment participation. This is a routine advisory council meeting announcement with no new compliance obligations.

CDC Proposes Data Collection Under Paperwork Reduction Act

CDC proposes a new data collection under the Paperwork Reduction Act and seeks public comments. The notice requests feedback on the proposed data collection, associated burden estimates, and collection methods. Comments are due June 15, 2026.

CDC Proposes Data Collection Under Paperwork Reduction Act

The CDC has published a notice proposing a new data collection under the Paperwork Reduction Act. The notice requests public comments on the proposed collection of information. The comment period closes 61 days from the date of publication.

CDC Agency Forms Undergo Paperwork Reduction Act Review

CDC published a notice announcing that certain agency forms are undergoing the Paperwork Reduction Act review process. The notice identifies forms under review by docket number 30Day-26-1335 and invites public comment on these information collections. Affected parties who submit information to CDC using these forms may wish to monitor the review for any changes to reporting requirements.

CMS Schedules June 2026 Public Meeting on HCPCS Level II Code Revisions

CMS announces the first biannual 2026 public meeting for HCPCS Level II coding to discuss preliminary coding, Medicare benefit category, and payment determinations for new non-drug and non-biological items and services. The primary meeting is scheduled for June 1, 2026, in Baltimore with a virtual overflow option on June 2, 2026. Speaker registration and in-person attendance requests are due by May 18, 2026, and written comments may be submitted until June 3, 2026.

Center for Scientific Review Notice of Closed Meetings

The National Institutes of Health Center for Scientific Review announces five closed meetings scheduled for May 12-13, 2026. The meetings will review and evaluate grant applications for clinical vision research, reproductive/perinatal/pediatric health, contraceptive development, immunity/host defense, and aging tissue research. Meetings are closed under provisions of the Federal Advisory Committee Act because discussions could disclose confidential trade secrets, commercial property such as patentable material, and personal information of individuals associated with grant applications.

Center for Scientific Review Notice of Closed Meetings

The NIH Center for Scientific Review announces five closed meetings scheduled for May 8, 2026. Review panels will evaluate grant applications in oncological sciences, medical informatics, genetics, endocrinology, and career development awards. Meetings are closed pursuant to the Federal Advisory Committee Act due to confidential grant information.

Increasing Access to Nonprescription Drugs; Public Meeting; Request for Comments

The FDA announced a public meeting on April 23, 2026 to gather stakeholder perspectives on increasing access to nonprescription drugs. The meeting will be held virtually and in person at the National Press Club in Washington, DC. Written and electronic comments are due by May 8, 2026.